Skip to main content
. 2020 Aug 11;7(4):ENEURO.0172-20.2020. doi: 10.1523/ENEURO.0172-20.2020

Figure 6.

Figure 6.

Farnesene favors high-sensitivity nAChRs in neuro-2a cells. A, α4β2 nAChRs assemble in two stoichiometries, and we observed that farnesene treatment shifts a mixed population of HS and LS α4β2 nAChRs to a majority of HS α4β2 nAChRs. B, In examining α4α6β2 nAChRs, under control treatments, ∼65% of the population are α4α6β2 nAChRs while the remainder is likely α4β2 nAChRs. Following treatment with farnesene, <14% of the nAChRs are α4α6β2 nAChRs.